Ligand · 0NV
0NV · 1-(1-benzylpiperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine
0NV, 1-(1-benzylpiperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine (C20 H21 N5, 331.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- 0NV
- Formula
- C20 H21 N5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
0NV in 2 structures; the first of them:
- 4E6Q · JAK2 kinase (JH1 domain) triple mutant in complex with compound 12 · 0NV A1201 · binds LEU855, GLY856, LYS857, GLY858, GLY861, SER862, VAL863, ALA880 and 14 more
- 4E6Q · JAK2 kinase (JH1 domain) triple mutant in complex with compound 12 · 0NV A1201 · binds LEU855, GLY856, LYS857, GLY858, GLY861, SER862, VAL863, ALA880 and 14 more
Residues it binds most
GLY 4, LEU 4, LYS 4, SER 4, VAL 4, GLU 4, ALA 4, ARG 4, ASN 4, ASP 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.